Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane, Lao PDR.


Journal

Transactions of the Royal Society of Tropical Medicine and Hygiene
ISSN: 1878-3503
Titre abrégé: Trans R Soc Trop Med Hyg
Pays: England
ID NLM: 7506129

Informations de publication

Date de publication:
02 10 2022
Historique:
received: 16 11 2021
revised: 11 02 2022
accepted: 10 03 2022
pubmed: 7 4 2022
medline: 5 10 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

The importance of autoimmune encephalitis and its overlap with infectious encephalitides are not well investigated in South-East Asia. We report autoantibody testing, using antigen-specific live cell-based assays, in a series of 134 patients (cerebrospinal fluid and sera) and 55 blood donor controls (sera), undergoing lumbar puncture for suspected meningoencephalitis admitted in Vientiane, Lao People's Democratic Republic (PDR). Eight of 134 (6%) patients showed detectable serum neuronal autoantibodies, against the N-methyl-D-aspartate and gamma-aminobutyric acid A receptors (NMDAR and GABAAR), and contactin-associated protein-like 2 (CASPR2). Three of eight patients had accompanying autoantibodies in cerebrospinal fluid (two with NMDAR and one with GABAAR antibodies), and in two of these the clinical syndromes were typical of autoimmune encephalitis. Three of the other five patients had proven central nervous system infections, highlighting a complex overlap between diverse infectious and autoimmune causes of encephalitis. No patients in this cohort were treated with immunotherapy, and the outcomes were poor, with improvement observed in a single patient. In Lao PDR, autoimmune encephalitis is underdiagnosed and has a poor prognosis. Empiric immunotherapy should be considered after treatable infectious aetiologies are considered unlikely. Awareness and diagnostic testing resources for autoimmune encephalitis should be enhanced in South-East Asia.

Sections du résumé

BACKGROUND
The importance of autoimmune encephalitis and its overlap with infectious encephalitides are not well investigated in South-East Asia.
METHODS
We report autoantibody testing, using antigen-specific live cell-based assays, in a series of 134 patients (cerebrospinal fluid and sera) and 55 blood donor controls (sera), undergoing lumbar puncture for suspected meningoencephalitis admitted in Vientiane, Lao People's Democratic Republic (PDR).
RESULTS
Eight of 134 (6%) patients showed detectable serum neuronal autoantibodies, against the N-methyl-D-aspartate and gamma-aminobutyric acid A receptors (NMDAR and GABAAR), and contactin-associated protein-like 2 (CASPR2). Three of eight patients had accompanying autoantibodies in cerebrospinal fluid (two with NMDAR and one with GABAAR antibodies), and in two of these the clinical syndromes were typical of autoimmune encephalitis. Three of the other five patients had proven central nervous system infections, highlighting a complex overlap between diverse infectious and autoimmune causes of encephalitis. No patients in this cohort were treated with immunotherapy, and the outcomes were poor, with improvement observed in a single patient.
CONCLUSIONS
In Lao PDR, autoimmune encephalitis is underdiagnosed and has a poor prognosis. Empiric immunotherapy should be considered after treatable infectious aetiologies are considered unlikely. Awareness and diagnostic testing resources for autoimmune encephalitis should be enhanced in South-East Asia.

Identifiants

pubmed: 35385878
pii: 6564377
doi: 10.1093/trstmh/trac023
pmc: PMC9526827
doi:

Substances chimiques

Autoantibodies 0
Contactins 0
Receptors, GABA-A 0
Receptors, N-Methyl-D-Aspartate 0
gamma-Aminobutyric Acid 56-12-2
N-Methylaspartate 6384-92-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

959-965

Subventions

Organisme : Wellcome Trust
ID : 104079/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205126/Z/16/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Références

Jpn J Infect Dis. 2003 Oct-Dec;56(5-6):193-9
pubmed: 14695429
Ann Neurol. 2011 May;69(5):892-900
pubmed: 21416487
Clin Infect Dis. 2006 Dec 15;43(12):1565-77
pubmed: 17109290
JAMA Neurol. 2017 Jan 01;74(1):50-59
pubmed: 27893017
J Clin Microbiol. 2014 Mar;52(3):832-8
pubmed: 24371248
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Emerg Infect Dis. 2019 May;25(5):898-910
pubmed: 31002063
Emerg Infect Dis. 2013;19(9):
pubmed: 23969035
Lancet Neurol. 2014 Feb;13(2):167-77
pubmed: 24360484
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
Ann Neurol. 2018 Mar;83(3):553-561
pubmed: 29406578
J Neurol. 2017 Jun;264(6):1127-1131
pubmed: 28470592
BMC Neurol. 2019 Nov 6;19(1):273
pubmed: 31694559
Medicine (Baltimore). 2016 Sep;95(37):e4365
pubmed: 27631202
Neurology. 2015 Mar 24;84(12):1233-41
pubmed: 25636713
J Neurol. 2021 May;268(5):1689-1707
pubmed: 31655889
Front Immunol. 2019 Nov 12;10:2611
pubmed: 31781111
Ann Neurol. 2014 Feb;75(2):317-23
pubmed: 24318406
Brain. 2010 Jun;133(Pt 6):1655-67
pubmed: 20511282
Lancet Psychiatry. 2019 Mar;6(3):235-246
pubmed: 30765329
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):291-294
pubmed: 33219046
Brain. 2010 Sep;133(9):2734-48
pubmed: 20663977
BMC Infect Dis. 2020 Jan 7;20(1):21
pubmed: 31910823
J Clin Neurol. 2014 Apr;10(2):157-61
pubmed: 24829602
J Neurol Sci. 2017 Feb 15;373:250-253
pubmed: 28131199
Brain. 2018 Feb 1;141(2):348-356
pubmed: 29272336
Mov Disord. 2014 Jan;29(1):90-6
pubmed: 24014096
J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):724-726
pubmed: 30032119
Ann Neurol. 2018 Jan;83(1):166-177
pubmed: 29293273

Auteurs

Christopher E Uy (CE)

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Nuffield Department of Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Division of Neurology, Department of Medicine, University of British Columbia Hospital, Vancouver, British Columbia V6T 2B5, Canada.
Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Mayfong Mayxay (M)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, New Richards Building, Oxford University, Oxford OX3 7LG, UK.
Institute of Research and Education Development (IRED), University of Health Sciences, Ministry of Health, Vientiane, Lao PDR.

Ruby Harrison (R)

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Nuffield Department of Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Adam Al-Diwani (A)

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Nuffield Department of Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.

Leslie Jacobson (L)

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Nuffield Department of Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Sayaphet Rattanavong (S)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.

Audrey Dubot-Pérès (A)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, New Richards Building, Oxford University, Oxford OX3 7LG, UK.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-INSERM 1207), IHU Méditerranée Infection, 19-21, Bd Jean Moulin, Marseille 13005, France.

Manivanh Vongsouvath (M)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.

Viengmon Davong (V)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.

Vilada Chansamouth (V)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, New Richards Building, Oxford University, Oxford OX3 7LG, UK.

Koukeo Phommasone (K)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.

Patrick Waters (P)

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Nuffield Department of Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Sarosh R Irani (SR)

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Nuffield Department of Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Paul N Newton (PN)

Lao-Oxford-Mahosot Hospital-Wellcome Research Unit OX3 7JX (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, New Richards Building, Oxford University, Oxford OX3 7LG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH